How to Switch GLP-1 Providers: Records, Refills and Care Transfer
Switch tirzepatide or semaglutide providers with a records checklist, pharmacy checks and clear billing terms. Your new provider decides your treatment plan.
More on Provider & Access
How do I switch tirzepatide providers?
Confirm that the new provider serves your state and offers the prescribed treatment you need. Share your medication label, prescribed dose, last injection date, treatment history, side effects and available records. Complete a new evaluation and ask for a written care and refill plan. The new provider decides whether to prescribe and what dose is appropriate. Confirm pharmacy fulfillment and review your old provider's cancellation terms before ending that service. A switch does not guarantee the same prescription or uninterrupted delivery.
Published by Trimi, a provider of compounded GLP-1 programs. This administrative guide is an editorial update, not a new clinician review or a personal dosing recommendation.
Why Patients Switch Providers
People compare GLP-1 providers because of billing terms, communication, relocation, insurance changes or treatment availability. Start with the medication and care your provider recommends. Changing services is not the same as changing medication, and a new provider must make an individual prescribing decision.
The Switching Checklist
1. Gather Your Records
Collect your medication label, prescribed dose, last injection date, treatment history, side effects, available medical records and labs, remaining supply and refill schedule. Tell the new provider about other medicines and any missed doses. Ask which additional records they need.
2. Research New Providers While Still Active
Confirm state availability and treatment options before enrolling. Check the provider's credentials and ask for the dispensing pharmacy's name and state license. Compare the full charge, billing term, required fees and cancellation conditions, rather than assuming an advertised monthly equivalent is a monthly bill.
3. Complete New Provider Evaluation
Share your records and complete the new provider's evaluation. The provider decides whether to prescribe and selects the treatment plan. Ask how missed doses or a treatment gap affect your individual plan. Approval, the same dose and the same preparation are not guaranteed.
4. Confirm Prescription Continuity
If a prescription is issued, confirm receipt, dispensing status and expected delivery with the pharmacy. Ask the provider or pharmacist to clarify the medication label and instructions before use. A vial from a different pharmacy may have a different concentration, so do not carry over syringe-unit instructions on your own.
5. Notify Your Previous Provider
Coordinate follow-up with both providers. Review the old service's renewal, cancellation and refund terms, obtain confirmation of any cancellation and keep copies of your records. Turning off renewal may not refund a prepaid term or remove an existing payment obligation.
If There Is a Treatment Gap
Tell the prescribing provider when you last used the medication and whether you had side effects. Ask for an individual restart plan before resuming, rather than assuming that your former dose still applies. There is no single restart rule in this guide for every GLP-1 medication, preparation and treatment gap. FDA advises patients with questions about compounded-drug instructions to contact their provider or compounder. See Trimi's provider-review and fulfillment process for the administrative steps.
Switching providers?
Bring your treatment records to Trimi
A licensed provider reviews your assessment and decides whether treatment is appropriate. Trimi's compounded tirzepatide monthly plan is $235 billed monthly. Its annual plan is $125 per month equivalent, billed $1,500 upfront for a 12-month commitment. Compounded medications are not FDA-approved. Review the plan charges and refund conditions before paying; completing checkout does not guarantee a prescription.
Start your online visitImportant: This guide covers care-transfer logistics. Your prescribing provider decides whether treatment, a continuation or a restart is appropriate. FDA recommends compounded drugs only when an FDA-approved drug cannot meet a patient's medical needs. They are not FDA-approved, and a prescription does not remove applicable compounding restrictions.
Frequently Asked Questions
How do I switch tirzepatide providers?
Confirm that the new provider serves your state and offers the prescribed treatment you need. Share your medication label, prescribed dose, last injection date, treatment history, side effects and available records. Complete a new evaluation and ask for a written care and refill plan. The new provider decides whether to prescribe and what dose is appropriate. Confirm pharmacy fulfillment and review your old provider's cancellation terms before ending that service. A switch does not guarantee the same prescription or uninterrupted delivery.
Will I need new lab work when switching providers?
Share available lab results and medical records with the new provider. Ask which records they accept and whether they need additional testing. There is no universal lab-age cutoff for every provider or patient.
Can I transfer my existing prescription to a new pharmacy?
Ask the dispensing pharmacy whether your specific prescription can be transferred under applicable rules. If a new prescription is needed, the new provider must evaluate you and decide whether to issue it. A provider switch and a pharmacy transfer are separate processes; neither guarantees the same preparation or dose.
What if there is a gap between providers?
Tell the prescribing provider the exact medication, dose and last injection date, including any missed doses or side effects. Ask for an individual restart plan before resuming. A previous dose does not establish the appropriate restart dose. For compounded medication, ask the provider or dispensing pharmacist to confirm the new label, concentration and injection instructions.
Can I consult a new provider before leaving my current one?
You can ask about a new service before canceling the old one. Tell both providers about your current treatment and any other prescriptions. Have them clarify who will manage refills and follow-up so that care is coordinated. Do not combine or alternate prescriptions from two providers on your own.
Discuss Your Care Transfer
Share your records and questions during the assessment. A provider decides your next treatment steps, and fulfillment timing can vary.
Get Started TodaySources & References
- FDA: concerns with unapproved GLP-1 drugs, dosing instructions and prescription-based care
- FDA: locate a state-licensed online pharmacy
- Trimi published plan charges and payment terms
- Trimi refund and cancellation conditions
Sources checked October 10, 2026. Branded-drug trial results are not used to promise results for compounded preparations.